Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Liver Extracellular Matrix in Colorectal Liver Metastasis.

Cancers·2025
Same author

Spheroids Composed of Reaggregated Neonatal Porcine Islets and Human Endothelial Cells Accelerate Development of Normoglycemia in Diabetic Mice.

Cells·2025
Same author

Determining safe washout period for immune checkpoint inhibitors prior to liver transplantation: An international retrospective cohort study.

Hepatology (Baltimore, Md.)·2025
Same author

Recreating the Endocrine Niche: Advances in Bioengineering the Pancreas.

Artificial organs·2025
Same author

Guidelines to Analyze Preclinical Studies Using Perinatal Derivatives.

Methods and protocols·2023
Same author

A new clinical severity score for the management of acute small bowel obstruction in predicting bowel ischemia: a cohort study.

International journal of surgery (London, England)·2023
Same journal

Tracking Synthetic Adhesins on Bacterial Surfaces with Immunofluorescence Microscopy.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Post-Selection Methods for Analyzing mRNA Display Selections and Optimization of Hits.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

High-Performance Computing in Tandem Mass Spectrometry (MS/MS) Peptide Identification.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Engineering and Adapting Disulfide-Containing Proteins to Enable Intracellular Functionality.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

AI-Driven Protein Research: From Prediction to Design.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Methods for the In Vitro Selection of Protein and Peptide Libraries Using mRNA Display.

Methods in molecular biology (Clifton, N.J.)·2026
See all related articles

Related Experiment Video

Updated: Aug 17, 2025

Generation of Scaffold-free, Three-dimensional Insulin Expressing Pancreatoids from Mouse Pancreatic Progenitors In Vitro
09:33

Generation of Scaffold-free, Three-dimensional Insulin Expressing Pancreatoids from Mouse Pancreatic Progenitors In Vitro

Published on: June 2, 2018

9.1K

Generation of Insulin-Producing Multicellular Organoids.

Laura Mar Fonseca1,2,3, Fanny Lebreton1,2,3, Charles-Henri Wassmer4

  • 1Laboratory of Tissue Engineering and Organ Regeneration, Department of Surgery, University of Geneva, Geneva, Switzerland.

Methods in Molecular Biology (Clifton, N.J.)
|December 12, 2022
PubMed
Summary
This summary is machine-generated.

This study details methods for creating insulin-secreting organoids, offering a promising alternative to clinical islet transplantation (CIT) for type 1 diabetes. These organoids aim to overcome CIT

Keywords:
Amniotic epithelial cellsDiabetesEndoC-BH1Insulin-secretingIsletsMulticellularOrganoids

More Related Videos

In Vitro Pancreas Organogenesis from Dispersed Mouse Embryonic Progenitors
08:35

In Vitro Pancreas Organogenesis from Dispersed Mouse Embryonic Progenitors

Published on: July 19, 2014

13.8K
Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters
08:41

Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters

Published on: June 23, 2023

3.2K

Related Experiment Videos

Last Updated: Aug 17, 2025

Generation of Scaffold-free, Three-dimensional Insulin Expressing Pancreatoids from Mouse Pancreatic Progenitors In Vitro
09:33

Generation of Scaffold-free, Three-dimensional Insulin Expressing Pancreatoids from Mouse Pancreatic Progenitors In Vitro

Published on: June 2, 2018

9.1K
In Vitro Pancreas Organogenesis from Dispersed Mouse Embryonic Progenitors
08:35

In Vitro Pancreas Organogenesis from Dispersed Mouse Embryonic Progenitors

Published on: July 19, 2014

13.8K
Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters
08:41

Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters

Published on: June 23, 2023

3.2K

Area of Science:

  • Regenerative Medicine
  • Endocrinology
  • Transplantation Biology

Background:

  • Clinical islet transplantation (CIT) for type 1 diabetes (T1D) improves glycemic control but faces limitations like donor scarcity, lifelong immunosuppression, and graft failure due to inflammation and ischemia.
  • Organoid generation is a promising regenerative medicine approach to address CIT limitations by enabling scalable production and improved graft survival.

Purpose of the Study:

  • To detail a stepwise methodology for generating insulin-secreting organoids using two distinct methods.
  • To describe in vitro quality assessment tests for these novel beta-cell replacement therapies.

Main Methods:

  • Generation of multicellular insulin-secreting organoids using islet cells and human amniotic epithelial cells (hAECs).
  • Detailed step-by-step protocols for organoid fabrication.
  • In vitro quality control assays for assessing organoid viability and function.

Main Results:

  • Successfully generated 3D insulin-secreting organoid structures.
  • Demonstrated improved viability and function of these organoids in vitro.
  • Previous in vivo studies showed enhanced graft survival and function.

Conclusions:

  • The described methodology provides a reproducible approach for generating insulin-secreting organoids.
  • These organoids represent a potential advancement over current clinical islet transplantation for T1D treatment.
  • Further research can optimize organoid generation for enhanced therapeutic efficacy and reduced immune rejection.